# Gut Microbiota, PGx and INSTIs Response

> **NCT04805944** · — · COMPLETED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 180 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Dolutegravir
- **DRUG:** Bictegravir
- **DRUG:** Dolutegravir
- **DRUG:** Dolutegravir
- **DRUG:** Bictegravir

## Key facts

- **NCT ID:** NCT04805944
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-10
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04805944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04805944, "Gut Microbiota, PGx and INSTIs Response". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04805944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*